Funding

HAPPE Spine received a second round of financing. The company is developing material technology that allows for the construction of partial or fully porous hydroxyapatite-reinforced PEEK implants.

Alphatec will receive US $30MM in secured debt financing from Squadron Capital. Proceeds will support company growth.

Medacta launches IPO with base size of CHF 547MM (USD $547.8MM), with 5.7 million shares offered at a price of CHF 96 (USD $96.1).

Hyalex Orthopaedics, developer of HYALEX synthetic polymer that is designed to mimic hyaline cartilage, grew its original Series A funding to US $33MM. 

Graftys completed a ‚¬4.1MM (~US $4.6MM) funding round. Proceeds will support commercialization of QuickSet cement and HBS injectable calcium phosphate bone graft substitute.

Tyber Medical was awarded a $225,000 grant to support research and development relating to a reduction in orthopedic surgical site infections.

The Magnesium Development Company received an investment from the cultivate(MD) Capital Fund II. MDC is developing a resorbable magnesium alloy technology with application in numerous orthopedic implantable devices.

OSSIO closed a US $22MM equity financing that will support commercialization of OSSIOfiber bone pin technology.

Embody received US $3.6MM to support pre-launch and pre-commercial activities for the Tapestry collagen-based microfiber implant, used in Achilles tendon and rotator cuff repairs.

Osso VR received National Science Foundation funding to support development of its virtual reality surgical training and assessment platform.